Clinical drug development Archives

Coronavirus

COVID-19 Returns in 20% of Patients Treated with Paxlovid

Chris Anderson -

November 14, 2023

Nutritionist calculating body mass index of woman for obesity treatment in a clinic room. Current research shows the gut microbiome may also influence risk for obesity.

News & Features

In Potential $2B Deal, AstraZeneca Licenses Oral GLP-1 Agonist for Weight Loss

Malorye Branca -

November 9, 2023

Triple negative breast cancer cell undergoing retraction and apoptosis

News & Features

Drug Targeting Protein May Be Key to Treating Triple-Negative Breast Cancer

Christina Jackson -

November 1, 2023

Close-Up Of Cropped Hands Inserting Syringe Into Vial of prototype gonorrhea vaccine

Informatics

AI Could Be Key to Developing mRNA Vaccine against Gonorrhea

Helen Albert -

November 1, 2023

Alzheimer's disease: illustration of the amyloid-beta 40 peptide (and others) accumulating to form amyloid fibrils that build up dense amyloid plaques.

News & Features

Alzheimer’s Vaccine Shows Good Safety, Immunogenicity at Phase II

Helen Albert -

October 25, 2023

PD-1 Antibody Targeting Immune Checkpoint Inhibitor

News & Features

Merck Bets Big on ADCs with $4B+ Daiichi Sankyo Deal

Malorye Branca -

October 20, 2023

Illustration of the prostate organ in blue surrounded by red cancer cells to symbolize prostate cancer

News & Features

New Xtandi Results Very Promising in Recurrent Prostate Cancer

Malorye Branca -

October 19, 2023

News & Features

Mounjaro Leads to Average 60lb Weight Loss in Latest Trial

Malorye Branca -

October 17, 2023

News & Features

BMS Acquires KRAS Targeter Mirati in $4.8B Deal

Malorye Branca -

October 10, 2023

IBD, Crohn's disease, ulcerative colitis

News & Features

Sanofi and Teva Ink Deal Worth Potentially $1.5B for Anti-TL1A IBD Candidate

Malorye Branca -

October 5, 2023

1 234...16 Page 3 of 16

Ultra-Low Energy MRI Shows Its Potential

Personal Vaccine Combined with Immune-Boosting Agent Improves Treatment of Malignant Glioma

DeepMind’s Next-Gen Protein Structure Predictor AlphaFold 3 Released

AI Improves Prostate Cancer Recurrence Prediction

Targeting Iron Uptake Shows Promise for Treating Asthma and Other Allergic…

Clinical drug development

COVID-19 Returns in 20% of Patients Treated with Paxlovid

In Potential $2B Deal, AstraZeneca Licenses Oral GLP-1 Agonist for Weight Loss

Drug Targeting Protein May Be Key to Treating Triple-Negative Breast Cancer

AI Could Be Key to Developing mRNA Vaccine against Gonorrhea

Alzheimer’s Vaccine Shows Good Safety, Immunogenicity at Phase II

Merck Bets Big on ADCs with $4B+ Daiichi Sankyo Deal

New Xtandi Results Very Promising in Recurrent Prostate Cancer

Mounjaro Leads to Average 60lb Weight Loss in Latest Trial

BMS Acquires KRAS Targeter Mirati in $4.8B Deal

Sanofi and Teva Ink Deal Worth Potentially $1.5B for Anti-TL1A IBD Candidate

Related Content

Targeting Iron Uptake Shows Promise for Treating Asthma and Other Allergic Diseases

Long COVID Symptoms in Children Vary by Age

Healthy Lifestyle Reduces Genetic Risk of Dying Early

Do COVID-19 mRNA Vaccines Boost Mucosal Immunity?